• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类血小板中非编码 RNA 在心血管疾病中的作用。

Role of Non-Coding RNA of Human Platelet in Cardiovascular Disease.

机构信息

Department of Clinical Biochemistry and Immunohaematology, Faculty of Health Sciences, Universidad de Talca, Talca, Chile.

Thrombosis Research Center, University of Talca, 2 Norte685, Talca, Chile.

出版信息

Curr Med Chem. 2022;29(19):3420-3444. doi: 10.2174/0929867329666211230104955.

DOI:10.2174/0929867329666211230104955
PMID:34967288
Abstract

Cardiovascular diseases (CVD) are the major cause of death in the world. Numerous genetic studies involving transcriptomic approaches aimed at the detailed understanding of the disease and the development of new therapeutic strategies have been conducted over recent years. There has been an increase in research on platelets, which are implicated in CVD due to their capacity to release regulatory molecules that affect various pathways. Platelets secrete over 500 various kinds of molecules to plasma including large amounts of non-coding (nc) RNA (miRNA, lncRNA or circRNA). These ncRNA correspond to 98% of transcripts that are not translated into proteins as they are important regulators in physiology and disease. Thus, miRNAs can direct protein complexes to mRNAs through base-pairing interactions, thus causing translation blockage or/and transcript degradation. The lncRNAs act via different mechanisms by binding to transcription factors. Finally, circRNAs act as regulators of miRNAs, interfering with their action. Alteration in the repertoire and/or the amount of the platelet-secreted ncRNA can trigger CVD as well as other diseases. NcRNAs can serve as effective biomarkers for the disease or as therapeutic targets due to their disease involvement. In this review, we will focus on the most important ncRNAs that are secreted by platelets (9 miRNA, 9 lncRNA and 5 circRNA), their association with CVD, and the contribution of these ncRNA to CVD risk to better understand the relation between ncRNA of human platelet and CVD.

摘要

心血管疾病(CVD)是世界上主要的死亡原因。近年来,人们进行了大量涉及转录组学方法的遗传研究,旨在深入了解该疾病并开发新的治疗策略。近年来,人们对血小板的研究有所增加,由于血小板能够释放影响各种途径的调节分子,因此它们与 CVD 有关。血小板向血浆中释放超过 500 种不同的分子,包括大量的非编码(nc)RNA(miRNA、lncRNA 或 circRNA)。这些 ncRNA 对应于 98%的非翻译转录本,因为它们是生理和疾病中的重要调节剂。因此,miRNA 可以通过碱基配对相互作用将蛋白质复合物引导至 mRNA,从而导致翻译阻断或/和转录降解。lncRNA 通过与转录因子结合发挥不同的作用。最后,circRNA 作为 miRNA 的调节剂发挥作用,干扰其作用。血小板分泌的 ncRNA 谱和/或数量的改变可能会引发 CVD 以及其他疾病。由于其与疾病的相关性,ncRNA 可以作为疾病的有效生物标志物或治疗靶点。在这篇综述中,我们将重点介绍由血小板分泌的最重要的 ncRNA(9 个 miRNA、9 个 lncRNA 和 5 个 circRNA),它们与 CVD 的关联,以及这些 ncRNA 对 CVD 风险的贡献,以更好地理解人类血小板 ncRNA 与 CVD 之间的关系。

相似文献

1
Role of Non-Coding RNA of Human Platelet in Cardiovascular Disease.人类血小板中非编码 RNA 在心血管疾病中的作用。
Curr Med Chem. 2022;29(19):3420-3444. doi: 10.2174/0929867329666211230104955.
2
Noncoding RNA crosstalk in brain health and diseases.非编码 RNA 串扰在大脑健康和疾病中的作用。
Neurochem Int. 2021 Oct;149:105139. doi: 10.1016/j.neuint.2021.105139. Epub 2021 Jul 16.
3
Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications.非编码 RNA 综述:从机制到治疗应用。
Biochem Pharmacol. 2024 Jun;224:116218. doi: 10.1016/j.bcp.2024.116218. Epub 2024 Apr 21.
4
Role of hedgehog signaling related non-coding RNAs in developmental and pathological conditions.Hedgehog 信号相关非编码 RNA 在发育和病理条件中的作用。
Biomed Pharmacother. 2022 Sep;153:113507. doi: 10.1016/j.biopha.2022.113507. Epub 2022 Aug 8.
5
Circular RNAs as a Diagnostic and Therapeutic Target in Cardiovascular Diseases.环状 RNA 作为心血管疾病的诊断和治疗靶点。
Int J Mol Sci. 2023 Jan 21;24(3):2125. doi: 10.3390/ijms24032125.
6
ncR2Met (lncR2metasta v2.0): An updated database for experimentally supported ncRNAs during cancer metastatic events.ncR2Met(lncR2metasta v2.0):一个在癌症转移事件中具有实验支持的 ncRNAs 的更新数据库。
Genomics. 2023 Mar;115(2):110569. doi: 10.1016/j.ygeno.2023.110569. Epub 2023 Feb 2.
7
Non-coding RNAs: the silent regulators of health and diseases.非编码 RNA:健康与疾病的沉默调控者。
Mol Biol Rep. 2022 Jul;49(7):6971-6973. doi: 10.1007/s11033-022-07464-4. Epub 2022 Apr 25.
8
Non-Coding RNA-Mediated Gene Regulation in Cardiovascular Disorders: Current Insights and Future Directions.非编码 RNA 在心血管疾病中的基因调控:当前的认识和未来方向。
J Cardiovasc Transl Res. 2024 Aug;17(4):739-767. doi: 10.1007/s12265-023-10469-4. Epub 2023 Dec 13.
9
Non-coding RNA in cancer.癌症中的非编码 RNA
Essays Biochem. 2021 Oct 27;65(4):625-639. doi: 10.1042/EBC20200032.
10
Non-coding RNAs and leaf senescence: Small molecules with important roles.非编码RNA与叶片衰老:发挥重要作用的小分子
Plant Physiol Biochem. 2024 Feb;207:108399. doi: 10.1016/j.plaphy.2024.108399. Epub 2024 Jan 23.

引用本文的文献

1
The role of notch signaling pathway and non-coding RNAs in cancer and inflammation: progress, therapeutic insights, and future directions.Notch信号通路和非编码RNA在癌症与炎症中的作用:进展、治疗见解及未来方向
Front Immunol. 2025 Jun 20;16:1567040. doi: 10.3389/fimmu.2025.1567040. eCollection 2025.
2
CircRNA and lncRNA-encoded peptide in diseases, an update review.环状 RNA 和长链非编码 RNA 编码肽在疾病中的研究进展综述
Mol Cancer. 2024 Sep 30;23(1):214. doi: 10.1186/s12943-024-02131-7.
3
Platelet-derived circFAM13B associated with anti-platelet responsiveness of ticagrelor in patients with acute coronary syndrome.
血小板衍生的环状FAM13B与急性冠脉综合征患者替格瑞洛的抗血小板反应性相关。
Thromb J. 2024 Jun 21;22(1):53. doi: 10.1186/s12959-024-00620-9.
4
The Novel Role of Noncoding RNAs in Modulating Platelet Function: Implications in Activation and Aggregation.非编码 RNA 在调节血小板功能中的新作用:在激活和聚集中的意义。
Int J Mol Sci. 2023 Apr 21;24(8):7650. doi: 10.3390/ijms24087650.
5
miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives.miRNA 在心脑血管疾病中的失调:现状与展望。
Int J Mol Sci. 2023 Mar 8;24(6):5192. doi: 10.3390/ijms24065192.
6
Epigenetic regulation of aging: implications for interventions of aging and diseases.衰老的表观遗传学调控:干预衰老和疾病的意义。
Signal Transduct Target Ther. 2022 Nov 7;7(1):374. doi: 10.1038/s41392-022-01211-8.